Pharmacists should expect ‘long term supply issues’ of metformin 500mg/5ml oral solution after manufacturers found it contained unacceptably high levels of a cancer-causing agent, the Department of Health and Social Care (DHSC) announced.
The widely used drug — which is used to treat and prevent type 2 diabetes — has been temporarily discontinued by its primary manufacturer and recalled by another after both found traces of N-nitrosodiethylamine (NDMA) impurities.
The drugs are currently undergoing testing and will be out of stock until testing is complete, DHSC said yesterday (13 September).
Limited supplies of metformin 500mg/5ml oral solution are expected to be made available at the beginning of October, however, these supplies of the drug will not be enough to support full demand.
Various formulations of the drug, including 850mg/5ml and 1000mg/5ml oral solutions and 500mg powder for oral solution remain available but cannot support any potential increase in demand.
Although supplies of metformin 500mg/5ml oral solution specials can be sourced, there is concern that these may also contain NDMA and therefore specials are only prescribed when ‘all other options have been exhausted’, PSNC said in its own update.
The following specialist importers have currently confirmed they can source unlicensed metformin 500mg/5ml oral solution:
Earlier this month, The Pharmacist reported that prescribing for diabetes in primary care now accounts for 12.5% of the total spend on all prescription items in England.
The cost of anti-diabetic drugs to the NHS, such as metformin, sulfonylureas and SGLT2 inhibitors has risen by 62% in the past five years to a high of £686 million, the NHS report showed.
Have your say
Please add your comment in the box below. You can include links, but HTML is not permitted. Please note that comments are not moderated before publication and the views expressed are those of the user and do not reflect the views of The Pharmacist. Remember that submission of comments is governed by our Terms and Conditions. You can also read our full guidelines on article comments here – but please be aware that you are legally liable for any libellous or offensive comments that you make. If you have a complaint about a comment or are concerned that a comment breaches our terms and conditions, please use the ‘Report this comment’ function to alert our web team.